Procurement Footprint
Pfizer — public-sector procurement footprint
From open OCDS records, AqlData resolved 407 name-spelling variants of Pfizer into one identity (150 legal entities) and mapped its public-sector footprint: 34 countries, ~$71.0B in awarded value, across 20,584+ tracked contracts (2003-07-21 – 2026-03-30).
34
countries
$71.0B
awarded value
20,584+
tracked contracts
2,092
public buyers
Geographic reach
| Country | Contracts | ~Value ($M) |
|---|---|---|
| EU | 2,218 | 19,178.4 |
| IT | 5,020 | 14,485.0 |
| GB | 370 | 12,786.7 |
| FR | 771 | 6,528.0 |
| DE | 374 | 6,270.3 |
| RO | 838 | 3,251.7 |
| + 28 more countries | in full report | — |
Top public buyers
| Buyer | Country | Contracts |
|---|---|---|
| Unidade Local de Saúde do Norte Alentejano, E. P. E. | PT | 407 |
| AZIENDA REGIONALE PER L INNOVAZIONE E GLI ACQUISTI S.P | IT | 273 |
| Instituto Português de Oncologia do Porto Francisco Ge | PT | 266 |
| + 2,089 more buyers — every agency, contract-level | — | in full report |
Activity over time
2015918
20161,141
20171,426
20182,177
20192,237
20202,231
20211,997
20222,904
20231,378
20241,344
2025595
202628
The full due-diligence report
All 34 countries, every one of 2,092 public buyers at the contract level, single-customer revenue concentration, the top-5 buyer split and the buyer-level competitor map — the complete Pfizer due-diligence brief, delivered within 24 hours.
Request a worked sample